| Pharmaceutical Information |
| Drug Name |
Nandrolone |
| Drug ID |
BADD_D01529 |
| Description |
Nandrolone, also known as 19-nortestosterone or 19-norandrostenolone, is a synthetic anabolic-androgenic steroid (AAS) derived from testosterone. |
| Indications and Usage |
|
| Marketing Status |
Not Available |
| ATC Code |
A14AB01; S01XA11 |
| DrugBank ID |
DB13169
|
| KEGG ID |
D08250
|
| MeSH ID |
D009277
|
| PubChem ID |
9904
|
| TTD Drug ID |
D00YWP
|
| NDC Product Code |
Not Available |
| Synonyms |
Nandrolone | 19-Nortestosterone | 17beta-Hydroxy-19-Nor-4-Androsten-3-One | 17beta Hydroxy 19 Nor 4 Androsten 3 One | Estrenolone | Nortestosterone | 17-Hydroxy-Estr-4-Ene-3-One | Norandrostenolone |
|
| Chemical Information |
| Molecular Formula |
C18H26O2 |
| CAS Registry Number |
434-22-0 |
| SMILES |
CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34 |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
